EP2118321A4 - Genemap of the human genes associated with endometriosis - Google Patents

Genemap of the human genes associated with endometriosis

Info

Publication number
EP2118321A4
EP2118321A4 EP08741999A EP08741999A EP2118321A4 EP 2118321 A4 EP2118321 A4 EP 2118321A4 EP 08741999 A EP08741999 A EP 08741999A EP 08741999 A EP08741999 A EP 08741999A EP 2118321 A4 EP2118321 A4 EP 2118321A4
Authority
EP
European Patent Office
Prior art keywords
genemap
endometriosis
genes associated
human genes
human
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP08741999A
Other languages
German (de)
French (fr)
Other versions
EP2118321A2 (en
Inventor
Abdelmajid Belouchi
John Verner Raelson
Bruno Paquin
Sandy Briand
Daniel Dubois
Eerdewegh Paul Van
Jonahan Segal
Randall David Little
Tim Keith
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genizon Biosciences Inc
Original Assignee
Genizon Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genizon Biosciences Inc filed Critical Genizon Biosciences Inc
Publication of EP2118321A2 publication Critical patent/EP2118321A2/en
Publication of EP2118321A4 publication Critical patent/EP2118321A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/172—Haplotypes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/178—Oligonucleotides characterized by their use miRNA, siRNA or ncRNA

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
EP08741999A 2007-02-06 2008-02-06 Genemap of the human genes associated with endometriosis Withdrawn EP2118321A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US89961507P 2007-02-06 2007-02-06
US94856507P 2007-07-09 2007-07-09
PCT/US2008/001529 WO2008123901A2 (en) 2007-02-06 2008-02-06 Genemap of the human genes associated with endometriosis

Publications (2)

Publication Number Publication Date
EP2118321A2 EP2118321A2 (en) 2009-11-18
EP2118321A4 true EP2118321A4 (en) 2010-06-30

Family

ID=39831514

Family Applications (1)

Application Number Title Priority Date Filing Date
EP08741999A Withdrawn EP2118321A4 (en) 2007-02-06 2008-02-06 Genemap of the human genes associated with endometriosis

Country Status (3)

Country Link
EP (1) EP2118321A4 (en)
CA (1) CA2676415A1 (en)
WO (1) WO2008123901A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080306034A1 (en) * 2007-06-11 2008-12-11 Juneau Biosciences, Llc Method of Administering a Therapeutic
US8932993B1 (en) 2007-06-11 2015-01-13 Juneau Biosciences, LLC. Method of testing for endometriosis and treatment therefor
US11287425B2 (en) * 2009-04-22 2022-03-29 Juneau Biosciences, Llc Genetic markers associated with endometriosis and use thereof
BR112013015605A2 (en) * 2010-12-24 2016-10-11 Otsuka Pharma Co Ltd bioanalysis method for physiologically active substance detection
US9434991B2 (en) 2013-03-07 2016-09-06 Juneau Biosciences, LLC. Method of testing for endometriosis and treatment therefor
EP3596100A4 (en) * 2017-03-15 2021-01-13 Juneau Biosciences, L.L.C. Methods of using genetic markers associated with endometriosis

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001032920A2 (en) * 1999-11-03 2001-05-10 Metris Therapeutics Limited Agents implicated in endometriosis
US20060014166A1 (en) * 2004-01-27 2006-01-19 Yossi Cohen Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of endometriosis
WO2006091254A1 (en) * 2005-02-18 2006-08-31 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Identification of molecular diagnostic markers for endometriosis in blood lymphocytes
WO2006116873A1 (en) * 2005-05-05 2006-11-09 Mount Sinai Hospital Diagnosis and treatment of endometriosis

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006116867A1 (en) * 2005-04-29 2006-11-09 Genizon Biosciences Inc. Genemap of the human genes associated with crohn's disease

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001032920A2 (en) * 1999-11-03 2001-05-10 Metris Therapeutics Limited Agents implicated in endometriosis
US20060014166A1 (en) * 2004-01-27 2006-01-19 Yossi Cohen Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of endometriosis
WO2006091254A1 (en) * 2005-02-18 2006-08-31 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Identification of molecular diagnostic markers for endometriosis in blood lymphocytes
WO2006116873A1 (en) * 2005-05-05 2006-11-09 Mount Sinai Hospital Diagnosis and treatment of endometriosis

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
BISCHOFF ET AL: "Heritability and molecular genetic studies of endometriosis", HUMAN REPRODUCTION UPDATE, OXFORD UNIVERSITY PRESS, OXFORD, GB LNKD- DOI:10.1093/HUMUPD/6.1.67, vol. 6, no. 1, 1 January 2000 (2000-01-01), pages 37 - 44, XP008112249, ISSN: 1355-4786 *
HSIEH Y-Y ET AL: "T homozygote and allele of epidermal growth factor receptor 2073 gene polymorphism are associated with higher susceptibility to endometriosis and leiomyomas", FERTILITY AND STERILITY, ELSEVIER SCIENCE INC, NEW YORK, NY, USA LNKD- DOI:10.1016/J.FERTNSTERT.2004.08.032, vol. 83, no. 3, 1 March 2005 (2005-03-01), pages 796 - 799, XP004776959, ISSN: 0015-0282 *

Also Published As

Publication number Publication date
WO2008123901A3 (en) 2009-02-19
WO2008123901A2 (en) 2008-10-16
EP2118321A2 (en) 2009-11-18
CA2676415A1 (en) 2008-10-16

Similar Documents

Publication Publication Date Title
EP2118320A4 (en) Genemap of the human genes associated with adhd
IL205571A0 (en) 4-pyrazolyl-n-arylpyrimidin-2-amines and 4-pyrazolyl-n-heteroarylpyrimidin
IL199955A0 (en) Pacemaker with pocsition sensing
IL210804A (en) Benzylidenehydrazides and uses thereof
EP1910569A4 (en) Genemap of the human genes associated with longevity
GB0708823D0 (en) Grommet
EP2302028A4 (en) Sequencer
GB0800702D0 (en) Genes
ZA201103456B (en) Leukolectins and uses thereof
EP2291377A4 (en) Imidazopyrimidinones and uses thereof
EP2328404A4 (en) Resistance genes
EP2318508A4 (en) Determination of the integrity of rna
EP2247601A4 (en) Thiazopyrimidinones and uses thereof
EP2118321A4 (en) Genemap of the human genes associated with endometriosis
IL202768A0 (en) Pirenzepine and derivatives thereof as anti-amyloid agents
EP2133326A4 (en) Novel pseudoglycolipid and use thereof
GB0715310D0 (en) Portable heater
ZA201000357B (en) 2-Azetidinemethaneamines and 2-pyrrolidinemethaneamines as Taar-Ligands
GB201004327D0 (en) The artin
GB0813359D0 (en) Halfin and/or platerfin
PL383157A1 (en) The manner of obtaining monochloropropandiols and dichloropropanols
PL381142A1 (en) The manner of obtaining of glicydol
GB0807277D0 (en) The club rest
GB0724733D0 (en) Sensing arrangement
PL382823A1 (en) The manner of obtaining of o-hydroxybenzyloamines

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20090903

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR

A4 Supplementary search report drawn up and despatched

Effective date: 20100602

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Effective date: 20100805